If you have questions or would like to share your own tips and experiences, feel free to leave a comment below
Piotrowski K, Becker M, Zugwurst J, Biller-Friedmann I, Spoettl G, Greif M, Leber AW, Becker A, Laubender RP, Lebherz C, Goeke B, Marx N, Parhofer KG, Lehrke M: Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans
Oral administration follows a ramping protocol: 250 micrograms daily for the first three weeks, increasing to 500 micrograms for maintenance
Key takeaways Nootropics are substances designed to support cognitive function
These drugs are expensive and often not covered by the patients health plan but off-label GLP-1RAs can lower the cost
Hypoglycemia, particularly in those using insulin or sulfonylureas, requires close monitoring